Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1991 | 12-1990 | 03-1990 | 12-1989 | 03-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 305 | -21 | -21 | -659 | -659 |
| Depreciation Amortization | 248 | 139 | 139 | 227 | 227 |
| Other Working Capital | 112 | 111 | 111 | -144 | -144 |
| Other Operating Activity | 0 | 0 | 0 | 417 | 417 |
| Operating Cash Flow | $665 | $229 | $229 | $-159 | $-159 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -474 | -48 | -48 | -91 | -91 |
| Other Investing Activity | 2,785 | -517 | -517 | -2,457 | -2,457 |
| Investing Cash Flow | $2,311 | $-564 | $-564 | $-2,548 | $-2,548 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 98 | -15 | -15 | 5,299 | 5,299 |
| Financing Cash Flow | $98 | $-15 | $-15 | $5,299 | $5,299 |
| Beginning Cash Position | 2,873 | 3,223 | 3,223 | 631 | 631 |
| End Cash Position | 5,947 | 2,873 | 2,873 | 3,223 | 3,223 |
| Net Cash Flow | $3,074 | $-350 | $-350 | $2,592 | $2,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | 665 | 229 | 229 | -159 | -159 |
| Free Cash Flow | 665 | 229 | 229 | -159 | -159 |